Kidney cancer trials in France

In France 57 Also abroad 485

57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Where
Angers, Dijon, Le Mans, Marseille, Nice Cedex 2, Paris, Saint-Priest-en-Jarez, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
758 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00
Phase 3Taking people
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Angers, Bordeaux Cedex, Brest, Caen Cedex 5, Clermont Ferrand Cedex1, Lille, Marseille, Montpellier Cedex 5, Paris, Poitiers, Reims, Rennes Cedex, Saint-Herblain Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
720 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00
Phase 1/2Taking people
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Where
Rennes Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandouvre Les Nancy, Villejuif
Age
18 years to 120 years
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Where
Bordeaux Cedex, Lille, Villejuif
Age
18 years and over
People
474 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00
Phase 1Taking people
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Where
Lyon, Paris, Toulouse Cedex 9
Age
18 years and over
People
300 worldwide
Run by
Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00
No phaseTaking people
Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
Where
Marseille
Age
18 years and over
People
60
Run by
Institut Paoli-Calmettes
See details and how to joinNCT06882486
No phaseTaking people
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Where
Boulogne-Billancourt, Paris
Age
18 years and over
People
100
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07739121
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Angers, Limoges Cedex I, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 1/2Taking people
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Where
Villejuif
Age
18 years and over
People
75 worldwide
Run by
Oncorena AB
See details and how to joinNCT05287945
Phase 1Not yet taking people in France
A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Marseille, Villejuif
Age
18 years and over
People
112 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295
Phase 3Taking people
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Where
71100, Ajaccio, Angers, Avignon, Bayonne, Besançon, Bordeaux Cedex, Boujan-sur-Libron, Boulogne-sur-Mer, Brest, Caen Cedex 5, Chalon Sur Saone Cedex, Chambéry, Clermont-Ferrand, Colmar Cedex, Compiègne, Creteil Cedex, Dax, Dijon, Epagny Metz-Tessy, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Lille, Limoges Cedex 1, Limoges Cedex I, Lyon, Marseille, Martinique, Mont-De-Marsan Cedex, Montpellier Cedex 5, Nice Cedex 2, Nimes Cedex 9, ORLEANS, Paris, Paris Cedex 20, Pau Cedex, Pierre-Bénite, Plérin, Poitiers, Reims, Rennes Cedex, Saint-Denis, Saint-Etienne, Saint-Mande, Saint-Priest-en-Jarez, St Herblain, St Nazaire, Strasbourg, Suresnes, Toulouse, Tours Cedex 9, Vandouvre Les Nancy, Villefranche-sur-Saône, Villejuif
Age
18 years and over
People
1,373 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-503317-29-00 · EU 2023-503317-29-00
Phase 1Not yet taking people in France
Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma
Where
Lyon
Age
18 years and over
People
26
Run by
Centre Leon Berard
See details and how to joinNCT07828249 · EU 2026-525526-38-00
Phase 1/2Taking people
Kidney cancer
Where
Villejuif
Age
18 years and over
People
105 worldwide
Run by
Oncorena AB
See details and how to join2023-505605-16-00 · EU 2023-505605-16-00
No phaseTaking people
Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
Where
Strasbourg
Age
18 years and over
People
100
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07820566
No phaseTaking people
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Where
Besançon, Levallois-Perret, Marseille, Neuilly, Paris
Age
18 years and over
People
2,285 worldwide
Run by
Guardant Health, Inc.
See details and how to joinNCT05059444
Phase 4Not yet taking people in France
Randomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy_POG
Where
Bron, Caluire-et-Cuire, Chevilly-Larue, Dijon, Lille Cedex, Lyon Cedex 04, Marseille, Paris, PARIS, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Cloud, Strasbourg Cedex 2, Toulouse, Villejuif
Age
65 years and over
People
794
Run by
Institut Gustave Roussy
See details and how to join2025-523610-83-00 · EU 2025-523610-83-00
Phase 4Not yet taking people in France
Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
Where
Villejuif
Age
70 years and over
People
794
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07802847
No phaseTaking people
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Where
Créteil, Lyon
Age
18 years and over
People
2,000 worldwide
Run by
Mark C Burgmans, MD PhD
See details and how to joinNCT07636148
Phase 1/2Taking people
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Where
Clermont Ferrand Cedex1, Dijon, La Tronche, Lyon, Marseille, Nantes, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy
Age
18 years and over
People
270 worldwide
Run by
Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00
Phase 1Taking people
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Bordeaux Cedex, Marseille, Villejuif
Age
18 years and over
People
281 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00
No phaseTaking people
Identification and Description of Patients With High-risk Non Metastatic RCC
Where
Bordeaux
Age
18 years and over
People
6,109
Run by
University Hospital, Bordeaux
See details and how to joinNCT07753343
Phase 1Taking people
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Where
Bordeaux, Villejuif
Age
18 years and over
People
307 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00
Phase 3Taking people
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Where
Angers, Bayonne, Bordeaux Cedex, Creteil Cedex, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Limoges Cedex I, Montpellier, Nancy, Pierre-Bénite, Rouen, Suresnes
Age
18 years and over
People
904 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00
Phase 4Taking people
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
Where
Avignon, Bayeux, Boulogne-sur-Mer, Caen, Caen Cedex 5, Coudekerque-Branche, Creil, Dijon, Epagny Metz-tessy, Lorient, Lyon, Montpellier Cedex 5, Mulhouse, Nice Cedex 2, Poitiers, St Etienne Cedex 2, Suresnes, Tours, Vannes
Age
18 years and over
People
83
Run by
Centre Francois Baclesse
See details and how to joinNCT07028125 · EU 2024-518991-30-00